Not logged in Share Save
Share Save
Share Save
Share Save
Inequality and heterogeneity in medical resources for children with autism spectrum disorders: a study in the ethnic minority region of southern China Lin, Yingying; Chen, Guozhi; Lu, Huaxiang; Qin, Rongfei; Jiang, Jinsheng; Tan, Weiwei; Luo, Caibin; Chen, Ming; Huang, Qin; Huang, Liangliang; Dong, Aihu; Qin, Jian Share Save
Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050 Pu, Xingxiang; Li, Juan; Zhang, Bo; Zhang, Jinyao; Mok, Tony S.; Nakagawa, Kazuhiko; Rosell, Rafael; Cheng, Ying; Zhou, Xiangdong; Miglorino, Maria Rita; Niho, Seiji; Lee, Ki Hyeong; Corral, Jesus; Pluzanski, Adam; Li, Junling; Linke, Rolf; Pan, Fang; Tang, Yiyun; Tan, Weiwei; Wu, Lin Share Save
Share Save
Vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, plus palbociclib in ER-positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: phase 1b cohort Hamilton, Erika; Jeselsohn, Rinath; Hurvitz, Sara; Juric, Dejan; Han, Hyo; Telli, Melinda; Zahrah, George; Nanda, Rita; Zhang, Yuanyuan; Tan, Weiwei; Duperret, Elizabeth; Zhi, Eric; Mather, Cecile; Schott, Anne Share Save
Share Save
Share Save
Vepdegestrant, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, in ER plus /human epidermal growth factor receptor 2 (HER2)- advanced breast cancer: Update of dose escalation results from a phase I/II trial Hamilton, E. P.; Han, H.; Schott, A.; Tan, A.; Nanda, R.; Juric, D.; Hunter, N.; Munster, P.; Fang, B.; Zahrah, G.; Ranciato, J.; Gedrich, R.; Zhi, E.; Zhang, Y.; Tan, W.; Mather, C.; Perkins, J.; Anderson, S.; Hurvitz, S. A. Share Save
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer (vol 12, 3697, 2021) Poels, Kamrine E.; Schoenfeld, Adam J.; Makhnin, Alex; Tobi, Yosef; Wang, Yuli; Frisco-Cabanos, Heidie; Chakrabarti, Shaon; Shi, Manli; Napoli, Chelsi; McDonald, Thomas O.; Tan, Weiwei; Hata, Aaron; Weinrich, Scott L.; Yu, Helena A.; Michor, Franziska Share Save
Share Save
Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198 Zhong, Jin-xiu; Kong, Yun-yuan; Luo, Rong-guang; Xia, Guo-jin; He, Wen-xing; Chen, Xue-zhong; Tan, Wei-wei; Chen, Qing-jie; Huang, Yu-yin; Guan, Yan-xing Share Save
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer Poels, Kamrine E.; Schoenfeld, Adam J.; Makhnin, Alex; Tobi, Yosef; Wang, Yuli; Frisco-Cabanos, Heidie; Chakrabarti, Shaon; Shi, Manli; Napoli, Chelsi; McDonald, Thomas O.; Tan, Weiwei; Hata, Aaron; Weinrich, Scott L.; Yu, Helena A.; Michor, Franziska Share Save
Share Save
Share Save
Share Save
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer Clark, Jeffrey W.; Camidge, D. Ross; Kwak, Eunice L.; Maki, Robert G.; Shapiro, Geoffrey I.; Chen, Isan; Tan, Weiwei; Randolph, Sophia; Christensen, James G.; Ozeck, Mark; Tang, Yiyun; Wilner, Keith D.; Salgia, Ravi Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
